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Abstract
Background: Previously manual human embryology in many in vitro fertilization (IVF) centers is rapidly being
replaced by closed embryo incubation systems with time-lapse imaging. Whether such systems perform
comparably to manual embryology in different IVF patient populations has, however, never before been
investigated.
We, therefore, prospectively compared embryo quality following closed system culture with time-lapse
photography (EmbryoScope™) and standard embryology.
We performed a two-part prospectively randomized study in IVF (clinical trial # NCT92256309). Part A involved 31 infertile
poor prognosis patients prospectively randomized to EmbryoScope™ and standard embryology. Part B involved embryos
from 17 egg donor-recipient cycles resulting in large egg/embryo numbers,
thus permitting prospectively alternative embryo assignments to EmbryoScope™ and standard embryology.
We then compared pregnancy rates and embryo quality on day-3 after fertilization and embryologist time utilized per
processed embryo.
Results: Part A revealed in poor prognosis patients no differences in day-3 embryo scores, implantation and clinical
pregnancy rates between EmbryoScope™ and standard embryology. The EmbryoScope™, however, more than doubled
embryology staff time (P < 0.0001). In Part B, embryos grown in the EmbyoScope™ demonstrated significantly poorer
day-3 quality (depending on embryo parameter between P = 0.005 and P = 0.01). Suspicion that conical culture dishes of
the EmbryoScope™ (EmbryoSlide™) may be the cause was disproven when standard culture dishes demonstrated no
outcome difference in standard incubation.
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Conclusions: Though due to small patient numbers preliminary, this study raises concerns about the mostly
uncontrolled introduction of closed incubation systems with time lapse imaging into routine clinical embryology.
Appropriately designed and powered prospectively randomized studies appear urgently needed in well-defined patient
populations before the uncontrolled utilization of these instruments further expands.
Trial registration: NCT02246309 Registered September 18, 2014.
Keywords: In vitro fertilization (IVF), Time laps photography, Closed incubation systems, Embryology, Embryo quality,
Cost-effectiveness
Background
Since its inception, improvements in the embryology la-
boratory have been a consisten goal of in vitro
fertilization (IVF). Over the years this has led to signifi-
cant changes in how human embryos are processed:
New culture media have been introduced [1, 2]; length
of embryo culture has in many IVF centers changed
from 2–3 days to 5–6 days) [3, 4]; and culture at re-
duced oxygen tension has been reported to improve em-
bryo development and clinical pregnancy rates [5, 6].
Increasingly, there has also been talk in recent years
about automating embryology, whether to improve qual-
ity or cost effectiveness [7–9].
It, therefore, was no surprise when in recent years a
series of automated closed incubation systems became
commercially available. They offered the additional
benefit of allowing consistent observation of embryo de-
velopment via time-lapse imaging (TLI), without need of
opening incubator doors, reported to be detrimental to
embryos [10, 11].
By minimizing environmental fluctuations in
temperature, pH and humidity, supporters of such
closed incubation systems have argued that embryo
quality would be improved and, therefore, clinical out-
comes. They also suggested that continuous time-lapse
documentation of embryo development would improve
embryo selection and, thereby, further improve preg-
nancy chances [12–16]. These instrumentations, how-
ever, entered the market place without clinical validation
for either claim. Till today it, therefore, is unknown
whether embryos from different patient populations (ie,
good vs. poor prognosis or younger vs, older patients)
are affected differently by such culture systems.
In traditional embryology, embryo selection is per-
formed manually and individually, trying to remove em-
bryos from controlled incubation only as rarely as
possible. Embryo assessment is, therefore, dependent on
experience and training of embryologists, and will vary [8].
Time-lapse imaging (TLI) systems, in contrast, offer
computer assisted, objective and non-invasive embryo
assessments. Continuous recording of all key develop-
mental events, at least hypothetically, allows for im-
proved embryo selection based on observations, which
would be missed by manual embryology. They, therefore,
have been alleged to improve embryo selection and clin-
ical pregnancy chances [17]. Several studies have claimed
early timing events to be predictive of blastocyst forma-
tion [12, 18, 19], implantation [20, 21] and pregnancy
[20, 22]. Currently available data appear, however, insuf-
ficient to support the conclusion that TLI systems, in-
deed, are helpful enough in embryo selection to improve
IVF cycle outcomes [11].
Several recent studies of TLI systems failed to achieve
improvements in embryo quality and other clinical out-
comes [23–26]. Park et al., indeed, reported a significant
increase in miscarriages after TLI [26].
Most so far reported studies of TLI have been anec-
dotal and uncontrolled. To the best of our knowledge,
only two prospectively randomized studies have so far
been reported [27, 28], one in very good prognosis pa-
tients reporting a marginal benefit for TLI [27] and the
other [28] reporting no difference to standard embry-
ology. Three systematic reviews also concluded that
there was no outcome benefit from TLI [11, 29, 30].
Moreover, IVF interventions that may be successful in
good prognosis patients, may lack benefits in other pa-
tient populations, like average-prognosis patients, and
have been demonstrated to be actually detrimental to
outcomes in poor-prognosis patients [31].
We, therefore, in this study attempted to asses the
clinical value of a TLI system in two distinct patient
populations: We, first, prospectively investigates a group
of poor-prognosis patients by randomizing them to TLI
and standard embryology. Secondly, we, however, inves-
tigated a group of egg donors as best-prognosis patients.
As this study will demonstrate, TLI systems in human
embryology laboratories requires careful evaluation be-
fore further integration into routine human IVF practice
since their effectiveness appears to be patient-
dependent.
Methods
Institutional review board (IRB)
Since the EmbryoScope™ was approved by The Food and
Drug Administration (FDA) for use in human embry-
ology laboratories, and has been integrated into routine
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embryology practice in many IVF centers, here reported
clinical trial (clinical trial registration # NCT02256309,
available at http://www.ClinicalTrials.gov) represented a
prospective clinical comparison of two standard embry-
ology practices in IVF, and was, therefore, approved by
our center’s IRB by expedited review. Patients signed an
appropriate informed consent.
Primary and secondary outcome measures
Primary outcome was clinical pregnancy rate per IVF
cycle start, with a clinical pregnancy being defined as a
pregnancy visualized by ultrasound and demonstrating a
normal fetal heart rate. Secondary outcomes were embry-
ologist time spent per embryo observation and embryo
quality.
Patient selection and randomization
Here reported study was restricted to 3.5 months bew-
een December 2014 and March 2015, the time period
our center (Center for Human Reproduction in New
York City) was offered free use of an EmbroScope™ by
the manufacturere. A follow-up study, which attempted
to determine potential causes for observed findings in
Part B of the study, was carried out between April and
June, 2015.
Part A of the study was an open-label prospectively
randomized clinical trial, offered during the study period
to consecutive patients undergoing autologous IVF
(+ICSI) cycles. The primary study outcome was clinical
pregnany. Anticipation was to recruit approximately 30
patients per month, resulting in a study population for
randomization of ca. 100 patients. We initiated the study
as a pilot study since power analysis suggested that the
expected patient number to detect at least 20 % differ-
ence in clinical pregnancy rates would, likely, be insuffi-
cient. Our hope was that the manufacturer might extend
our access to the equipment beyond 3 months to reach
required numbers for statistical power. Power analyses
of secondary outcomes, including embryo parameters,
and time analysis of embryologists, suggested need for
fewer patients/ cycles to reach statistically valuable infor-
mation. We, therefore, assumed that without extended
availability of the instrument, we still should be able to
assess potentially important secondary outcomes with
adequate statistical power.
Figure 1 summarized the CONSORT flowchart for this
trial: In part A of the trial 134 patients were offered par-
ticipatation during the study period. To our surprise
only 49 qualified and/or consented to participate by in-
formed consent. Computer randomization to either TLI
or standard embryology was the responsibility of a mem-
ber of the center’s Statistics Section (SKD) who was
completely disassociated from the patient’s IVF cycle.
The designation was then reported to the embryology
staff, which processed the patient’s oocytes/embryos
accordingly.
Related to our center’s adverse patient selection, the final
number of women undergoing randomization for part A was
only 31 (Panel a) after exclusion of other patients. Table 1
demonstrates that, based on age and/or functional ovarian
reserve parameters (FSH and AMH), they, indeed, were
poor-prognosis patients. As such, they also, as expected, pro-
duced relative small oocyte and embryo numbers, prohibit-
ing inter-embryo randomization, and mandating transfer of
all transferrable embryos. Panel b describes part B of the
study, where embryos in donor recipient cycles were
randomized prospectively rather than patients.
Such inter-embryo randomization among individual pa-
tients is, however, possible in young egg donors, who rou-
tinely produce large oocyte and embryo numbers. In Part
B of this study, we, therefore, separated during the study
period egg donor cycles from autologous IVF cycle. More-
over, egg donors were not randomized but, within each
donor egg cycle, alternating embryos were either assigned
to TLI or standard embryology. This part of the study,
thus, prospectively assigned 76 embryos from 7 oocyte
donor/recipient cycles (CONSORT flow chart in Fig. 1b),
and the assignment was done in non-blinded fashion by a
senior embryologist. Table 2 summarizes patient charac-
teristics of Part 2 patients (oocyte donors).
Assessment of the EmbryoSlide™
Since results of Part B of the study suggested significant
outcome differences between TLI and standard embry-
ology, we wanted to determine whether the conical cul-
ture dish in the EmbryoScope™ (EmbryoSlide™) might be
the culprit. The hypothesis was that embryos may be
incubating at the bottom of the conical well, surrounded
by excretion products, which might adversely affect
embryo quality.
The assessment of this hypothesis was no longer
dependent on availability of the EmbryoScope™. This
study was, therefore, extended by approximately 3
months to determine whether the conical form of the
EmbryoSlide™ was, indeed, the culprit. We had pur-
chased excessive numbers of EmbryoSlides™ for the clin-
ical trial of the EmbryoScope™, which now were used
prospectively. Ten additional donor-recipient cycles (132
embryos) were utilized to culture embryos in standard
incubators, alternating in EmbryoSlides™ and flat stand-
ard culture dishes, our center routinely uses.
Our center implements changes in the embryology
laboratory’s routine only very cautiously. Before imple-
menting a change, the laboratory’s routine is compared
prospectively to the potentially new product/procedure.
The center’s Institutional Review Board (IRB) does not re-
quire prior review of such comparisons if alternative
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products/procedures reflect standard of care and/or have
received approval from the Food and Drug Administration
since such investigations are considered part of the labora-
tory’s continous quality improvement program.
This part of the study, therefore, did not undergo IRB
review.
Patient stimulation and IVF procedure
All subjects underwent controlled ovarian hyperstimula-
tion and oocyte maturation by human chorionic gonado-
tropin (hCG), followed by transvaginal ultrasound-
guided oocyte retrieval. hCG was administered when
leading follicles reached 19–21 mm. Oocyte donors were
stimulated in a long gonadotropin releasing hormone
agonist cycle (GnRHa, Lupron, leuprolide acetate,
Takeda Pharmaceutical U.S.A Inc) with daily dosages of
150–300 I.U. of human menopausal gonadotropin
(hMG) from various manufacturers. In contrast, infertil-
ity patients were stimulated in microdose agonist cycles
(Lupron) with daily dosages of 450–600 I.U. of gonado-
tropins, typically in a majority (300–450 I.U.) adminis-
tered as follicle stimulating hormone (FSH), and in a
minority (150I.U.) as hMG.
All media and reagents for IVF were purchased from
LifeGlobal (Guilford, CT, USA) unless indicated other-
wise below. For blastocyst culture their Global®Total®
media was used. Oocyte-cumulus complexes (COCs)
were collected using transvaginal ultrasound guided fol-
licle punctures in mHTF, containing 6 % human serum
albumin (HSA). Before ICSI, COCs were cultured in
HTF, containing 10 % HSA in an organ dish (Falcon,
VWR, NJ, USA). After removal of cumulus by 30 s of
hyaluronidase treatment, oocytes were assessed accord-
ing to morphology. Oocytes with obvious first polar
body (1st Pb) were identified as mature (MII), and used
for ICSI. ICSI was performed under an inverted micro-
scope (Olympus, Japan) within six hours of oocyte re-
trieval in mHTF, containing 6 % HAS.
Table 1 Patient and cycle characteristics of study Part A
IVF information and characteristics EmbryoScopeTM (N = 16) Standard (N = 15) P value
Average age (years) 38.8 ± 1.0 40.4 ± 1.8 0.65
Average serum FSH (mIU/ml) 9.2 ± 1.2 10.8 ± 1.6 0.46
Average serum AMH (ng/ml) 1.1 ± 0.5 0.9 ± 0.3 0.74
Number of oocytes/patient (n) 5.3 ± 0.9 4.4 ± 0.7 0.52
N number of patients
a
b
Fig. 1 Consort flow diagram for the TLI culture randomized control trial (ClinicalTrials.gov NCT02256309)
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Embryo culture
Standard embryology
For the standard embryo culture group, oocytes after
ICSI were washed in blastocyst medium containing 10 %
HSA, and then transferred to pre-equilibrated culture
dish (Thermo, Oskilde, Denmark), with 20 μl droplets of
blastocyst medium containing 10 % HSA under light oil.
The embryos were cultured until transfer in a standard
incubator (Panasonic, Japan) at 37 °C, 5 % CO2 and
90 % N2 for 3 days. The embryos were taken out of the
incubator at 16–18 h post injection for fertilization
check, at 40–42 h post ICSI for early cleavage evalu-
ation, and at 64–66 h post ICSI for quality assessment of
transfer and cryopreservation. The time used for each
check and assessment was recorded.
TLI embryology
For TLI embryo culture group (EmbryoScopeTM), oo-
cytes were washed in the same way as described above
for the standard embryology group. We utilized in this
study the EmbryoScopeTM (Vitrolife, Göteborg, Sweden),
a commercial, FDA-approved TLI system. It is made up
of an incubator with a built-in microscope, which ac-
quires images of cultured embryos continuously. In this
study, we acquired images every 10 min at seven focal
planes.
Pre-equilibrated embryo culture dishes (EmbryoSlide™,
Vitrolife, Göteburg, Sweden) were used in conjuction
with the EmbryoScopeTM, which were prepared by fol-
lowing the manufacturer’s instruction. Briefly, each well
contained 25 μl of Blastocyst medium containing 10 %
HAS, and the whole dish was covered with 1.5 ml of light
oil. After ICSI, individual oocytes were loaded to the center
of the well and cultured in the EmbryoScopeTM at 37 °C,
5 % CO2, %5 O2 and 90 % N2 atmosphere for 3 days until
transfer. The images taken by the TLI were reviewed at
16–18 h post injection for fertilization check, at 40–42 h
post ICSI for early cleavage evaluation, and at 64–66 h
post ICSI for embryo quality assessment for embryo trans-
fer and cryopreservation. The embryology staff time used
for each check and assessment was recorded.
Assessment of embryology staff time
The time embryologists used on either embryology
method was timed by a standard lab timer. For standard
culture, timing was taken from when a culture dish was
removed from the incubator until the dish was returned
back into the incubator. For TLI culture, timing was
started when the embryologist began to check a first em-
bryo’s morphology and discontinued with completion of
the last embryo’s check. To avoid the subjective differ-
ence of different observers, all embryo checking/selec-
tion and time recording were performed only by one
embryologist.
Comparison of standard embryo culture dish and
EmbryoSlide™
Oocytes were loaded as described above. Comparing out
center’s standard culture dish to EmbryoSlide™, both were
prepared as described before, were and injected and were
cultured in a standard incubator at 37 °C, 5 % CO2 and
90 % N2 atmosphere for 3 days until transfer. Embryos in
both dishes were taken out of the incubator at 16–18 h
post injection for fertilization check, at 40–42 h post ICSI
for early cleavage evaluation, and at 64–66 h post ICSI for
embryo quality assessment for embryo transfer and
cryopreservation.
Embryo assessment and selection on day 3
For all groups of embryo in this study, morphological
assessments and selection for embryo transfer were per-
formed at the same time point (64–66 h post ICSI) and
using the same criteria. Additional information from TLI
was not considered for embryo assessment and selection.
On day 3, at 64–66 h post ICSI, embryos were
scored according to blastomere numbers, size and
amount of fragmentation. Embryos of Grade A (high
quality) had ≥ 8 blastomeres with equal size, <10 %
fragmentation or slightly unequal size and no frag-
mentation; Embryos of Grade B (fair quality) had ≥ 6
blastomeres with equal size, <25 % fragmentation or
slightly unequal size and <10 % fragmentation; Em-
bryos of Grade C (poor quality) had > 25 % fragmen-
tation or blastomeres with severely unequal size.
Examples for embryo grading criteria are demon-
strated in Fig. 2. Embryos of grade A and B were
considered suitable for transfer or cryopreservation.
All embryo transfers were carried out on day-3, within
2 h from the embryo quality assessment. Panels a and b
(Grade A) demonstrate best quality embryos; Panels c
Table 2 Patient (oocyte donors) and cycle characteristics of study Part B
IVF information and characteristics EmbryoScopeTM vs. Standard (N = 7) EmbryoSlideTM vs. Standard dish (N = 10)
Average age (years) 27.8 ± 1.4 26 ± 0.9
Average serum AMH (ng/ml) 4.3 ± 1.1 6.1 ± 0.9
Number of oocytes/donor (n) 17.3 ± 2.8 19.3 ± 1.8
N number of patients
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and d depict intermediate grade embryos (Grade B); and
Panels e and f show worst grade embryos (Grade C).
Statistical analysis
All statistical analyses were performed using Prism soft-
ware (GraphPad Prism 6.0, GraphPad Software. Inc, CA,
USA). The unpaired t-test with Welch’s correction was
used for all statistical comparisons. Data in all tables are
shown as value ± SEM. Values were considered statisti-
cally significant at P < 0.05.
Results
Part A: TLI system vs. standard embryo culture system
system in infertile women
Patient comparisons
Randomization of 31 infertile patients resulted in 16 patients
going through TLI and 15 through standard embryology
(Fig. 1a). Patient and IVF cycle characteristics involved in
this study are summarized in Tables 1 and 2: Mean age in
the EmbryoScopeTM group (38.8 ± 1.0 years) was non-
significantly lower than in the standard embryology group
(40.4 ± 1.8 years). Similarly, FSH, AMH and number of
retrieved oocytes (5.3 ± 0.9 vs. 4.4 ± 0.7) did not differ,
suggesting a credible randomization process.
Pregnancy rates
A total of 44 fertilized oocytes from 16 patients were
cultured in the EmbryoScopeTM, and 42 fertilized
oocytes from 15 patients were cultured in standard
incubators. Embryo numbers per patient cultured in
EmbryoScopeTM and standard incubators were similar
(2.7 ± 0.4 vs. 2.8 ± 0.4). No differences were also noted
in number of good quality embryos, defined as Grade
A on day 3 (1.2 ± 0.3 vs. 1.2 ± 0.2), fair quality em-
bryos, Grade B on day 3 (0.9 ± 0.2 vs. 0.9 ± 0.3) and
poor quality embryos (Grade C on day 3; 0.4 ± 0.2 vs.
0.6 ± 0.2) (Table. 3). The clinical pregnancy rate per
randomized patient was 18.8 % in the EmbryoSco-
peTM group and 20.0 % in the standard embryology
group, and implantation rates were 9.7 and 11.5 %,
respectively. Considering the adverse selection of pa-
tients in Part A, these IVF cycle outcomes have in
both groups to be considered as respectable, though
not remarkable.
In a population of relative poor prognosis patients,
embryos cultured in a TLI system and by standard em-
bryology up to day-3, thus, demonstrated similar devel-
opment and similar implantation as well as clinical
pregnancy rates. The small number of investigated pa-
tients, however, does not preclude the possibility of a
type 2 error. In other words, this study does not pre-
clude the possibility that a larger patient population
might demonstrate significant differences between TLI
and standard embryology. It in this context is important
to note that all non-significantly different outcomes did
trend in favor of standard embryology.
Fig. 2 Grades for human embryo of day 3 cultured in vitro. Panels a and b (Grade A) demonstrate best quality embryos; Panels c and d depict
intermediate grade embryos (Grade B); and Panels e and f show worst grade embryos (Grade C)
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Time study
Table 4 demonstrates that, in contrast to clinical out-
comes, staff time both embryo culture systems required,
significantly differed: The EmbryoScopeTM more than
doubled the required transaction time (301.2 ± 80.8 s)
per embryo compared to standard embryology (137.6 ±
2.7 s; P < 0.0001).
Part B. TLI system vs. standard embryo culture system in
young oocyte donors
Table 5 summarizes embryo grades of 7 oocyte donors
whoes oocytes/embryos were randomly assigned to ei-
ther the EmbryoScope™ or to the center’s standard embry-
ology. Among 36 embryos cultured in the EmbryoScopeTM,
55.8 ± 6.4 % were of grade A, a significantly lower percent-
age than achieved with standard culture (81.2 ± 4.1 % of 40;
P = 0.005). Moreover, there were more grade B embryos in
the EmbryoScopeTM than in the standard embryology
group (36.8 ± 8.5 vs. 7.4 ± 4.1 %, P = 0.01), while numbers of
embryos with poor quality (grade C, not suitable for trans-
fer or cryopreservation) were similar (7.3 ± 5.7 vs. 11.0 ±
4.7 %, P = 0.62).
These findings suggest that, though the total number
of usable embryos (Grade A +Grade B) was not affected
by the two culture systems, standard embryo culture
generated significantly better culture results since ap-
proximately 25 % of all embryos in the EmbryoScopeTM
system ended up one grade below those handeled in
standard embryology.
Part B did not allow for evaluation of pregnancy rates
because patients were transferred good quality embryos
in combination from both culture systems.
Investigation id EmbryoSlide™
Suspecting the conical shape of the culture dishes
(EmbryoSlide™) to be the reason for the inferior per-
formance of the EmbryoScopeTM, we then prospectively
tested another 132 consecutively produced embryos
from 10 egg donor cycles by alternating them in stand-
ard embryo culture for 3 days (up to cleavage stage) in
an open incubator between EmbryoSlide™ (n = 68) and
our center’s standard culture dish (n = 64).
Table 6 demonstrates no difference in embryo quality
between both culture dishes. These findings suggest that
differences in embryo quality between the EmbryoScope™
and standard embryology in Part B was not caused by var-
iations in embryo culture dishes between the two systems
but, likely, reflected the culture environment of the
EmbryoScope™.
Discussion
Universal efficacy and safety of embryo selection via
use of TLI embryo culture systems in human IVF la-
boratories has so far not been established [11]. More-
over, maybe even more importantly, whether these
closed culture systems are clinically equally effective
in different patient populations has never before been
investigated.
Embryos of good and poor prognosis or of younger
and older women are known to behave differently during
in vitro culture. The aim of this study was, therefore,
twofold: (i) to assess whether a TLI system achieves
similar IVF outcomes to standard manual embryology;
and (ii) whether the efficacy of a TLI system is the same
in better and poorer prognosis patients.
Our center does not change laboratory pratices
without prior assessments of non-inferiority and,
hopefully, determination of superiority. Before pur-
chasing a closed incubation system, we, therefore,
contacted different manufacturers in attempts to per-
form a prospectively randomized pilot study to assess
how such a system would perform in our center’s
highly adversely selected patient population. Only
one, the manufacturer of the EmbryoScope™, gra-
ciously agreed to provide us with a loaner instrument
for a 3-months study period. Intarmural research
funds were used to pay for installation of the instru-
ment, staff training and supply costs. The study only
commenced, once the manufacturer was confident
that our center’s embryology staff was competent in
using the instrument.
Table 3 Outcome comparisons in study Part A
Embryo development and outcomes EmbryoScopeTM (N = 16) Standard (N = 15) P value
Number of Total embryos per patient (n) 2.7 ± 0.4 2.8 ± 0.4 0.93
Number of Grade A embryos per patient (n) 1.2 ± 0.3 1.2 ± 0.2 >1.0
Number of Grade B embryos per patient (n) 0.9 ± 0.2 0.9 ± 0.3 >1.0
Number of Grade C embryos patient (n) 0.4 ± 0.2 0.6 ± 0.2 0.99
Pregnancy rate (%) 18.8 20.0 >1.0
Implantation rate (%) 9.7 11.5 >1.0
Since this study involved poor prognosis patients, all transferrable embryos obtained in a cycle were transferred
N number of patients
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Limited time availability of the system resticted the
number of patients we were able to investigate. Here
presented conclusions, therefore, should be considered
as preliminary, even though they in important aspects
are based on statistically significant results.
Prospective randomization of poor prognosis patients
(Part A)
Part A prospectively investigated randomized patients
with relatively poor prognosis between tradional embry-
ology and the EmbryoScope™. When our investigation
was initiated, the instrument had been investigated in
only one RCT, involving very favorably selected patients
That study reported the instrument to marginally im-
prove IVF outcomes (27). As effectiveness of some IVF
interventions differs between good-, intermediate- and
poor-prognosis patients [31], we felt the need to assess
its efficacy in our patient population before committing
to a purchase. Ages, FSH and AMH levels of here inves-
tigated patients (Table 1) reflect the poor outcome prog-
nosis of our patients in comparison to the Spanish study
by Rubio et al. [27].
That in contrast to their study no outcome benefits
from the EmbryScope™ were seen in our investigation is,
therefore, noteworthy. Our findings may suggest that
closed incubation systems in different patient popula-
tions may demonstrate different degrees of efficacy. The
small size and, therefore, inadequate power of our study,
however, does not preclude a Type 2 error in failing to
demonstrate an outcome difference in Part A of this
study. Significant outcome differences may only become
apparent with larger patient numbers. Since observed
implantation and pregnancy rates actually trended to-
ward traditional embryology (Table 3), a potential out-
come benefit from the instrument over standard
embryology, however, appears unlikely.
No differences (ie, no improvements) in embryo devel-
opment with TLI systems have been reported before
[19–21, 28–32]. One study, indeed, suggested increased
miscarriage rates with use of a TLI system [26]. As also
suggested by Racowsky et al. [11], whether TLI systems
really offer outcome benefits over standard embryology,
therefore, remains questionable,
Embryology staff time
In promotional efforts, manufactueres of TLI systems
also have claimed that these systems save embryology
staff time. In this first investigation of such a claim
claim, as Table 4 demonstrates, the EmbryoScope™ al-
most doubled embryo observation times in comparison
to standard embryology. Trying to determine the
cause(s), we discovered that the instrument required re-
peated adjustment of focus because initial monitor im-
ages were not as clear as with manual inverted
microscopy. Embryo scoring was also more challenging
since embryos tended to migrate toward the sides of
wells, as also reported by Park et al. [26]. The Embryo-
Scope™, thus, does not appear to save embryology staff-
ing time, and, indeed, may increase staffing needs.
Randomization of embryos in best prognosis patients
(Part B)
Part B of this study was intended to assess the instru-
ment in “best” prognosis patients. In using young oocyte
donors, large oocyte yields allowed open randomization
of embryos between EmbryoScope™ and standard em-
bryology in place of patient randomization. In the previ-
ously noted Spanish RCT, oocyte donors represented
almost half of the patient population [27]. The intent,
therefore, was to investigate performance of the TLI sys-
tem in best-prognosis patients, even exceeding the favor-
able patient selection of the Spanish study.
Table 4 Comparison of embryologists’ time usage in study Part A
Time usage for embryo check per embryo (seconds) EmbryoScopeTM (N = 16; n = 44) Standard (N = 15; n = 42) P value
Day 1 (fertilization check) 99.0 ± 34.1 49.8 ± 17.0 P < 0.0001
Day 2 (Cleavage check) 98.6 ± 32.2 47.8 ± 14.9 P < 0.0001
Day 3 (Selection for transfer) 103.6 ± 23.9 54.1 ± 17.9 P < 0.0001
Total 301.2 ± 80.8 137.6 ± 52.7 P < 0.0001
N number of patients, n number of embryos
Table 5 Embryo quality comparison in study Part B
Embryo grades EmbryoScopeTM (n = 36) Standard (n = 40) P value
Grade A (%) 55.8 ± 6.4 81.2 ± 4.1 0.005
Grade B (%) 36.8 ± 8.5 7.7 ± 4.1 0.01
Grade C (%) 7.3 ± 5.7 11.0 ± 4.7 0.62
N number of oocyte donors, n number of embryos
Table 6 Embryo quality after culture in EmbryoSlildes™ and
standard culture dishes in standard open system incubators
Embryo grades EmbryoSlide (n = 68) Standard dishe (n = 64) P value
Grade A (%) 79.7 ± 3.8 80.1 ± 2.4 0.83
Grade B (%) 9.8 ± 3.1 13.1 ± 3.8 0.44
Grade C (%) 10.3 ± 4.4 7.5 ± 3.0 0.61
N number of oocyte donors, n number of embryos
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Since based on the Spanish study we expected im-
provements in IVF outcomes, we were surprised to ob-
serve the opposite. We were further surprised by the
statistical power of observed outcome differences, even
though small numbers call for caution in interpretation:
Despite the relative small study size (Table 5), the
EmbryoScope™ produced significantly fewer Grade A
and, therefore, significantly more Grade B embryos than
standard embryology, suggesting a potentially negative
impact of the TLI system on embryo quality.
Observing these rather surprising results raised the ques-
tion whether staff members operating the EmbryoScope™
had been sufficiently trained. We, therefore, reviewed em-
bryology staffing records, and found that the embryologists
handling the instrument during Parts A and B of here re-
ported study were exactly the same. Insufficient staff train-
ing, therefore, only unlikey explains the findings of this
study.
Our suspicion then fell on the culture dish of the
EmbryoScope™, called the EmbryoSlide™. It is a single-
use, sterile culture dish, especially designed for the
EmbryoScopeTM incubator. Each EmbryoSlide™ holds up
to 12 embryos, each cultured individually in droplets of
25 μl media. They, therefore, are cultured in relative low
density and not grouped together. In contrast, conven-
tional dishes, as utilized at our center, culture up to 5
embryos in 50 μl droplets.
Higher embryo density group culture has been re-
ported to benefit embryo development [16, 33], possibly
the consequence of one or more factors produced by
embryos, which can stimulate embryo development [34].
We, therefore, parallel cultured alternating donor em-
bryos in EmbryoSlides™ and standard embryo culture
dishes in the same incubation environmentone (Table 6).
As the table demonstrates, this additional prospective
evaluation by day-3 of culture demonstrated no differ-
ence in embryo quality between both embryo culture
dishes. The EmbryoSlide™, therefore, apparently was not
the cause of our observation.
This left us with no established cause for our observa-
tion, and the conclusion that the incubation envriron-
ment in the EmbryoScope™, likely, was inferior to our
center’s standard embryo culture environment. Such an
explanation is not farfetched: Several physical factors
can impact final embryo development during in vitro
culture, including incubation volume/embryo density,
temperature/pH and light as well as shear stress from
mechanical motion [34]. Even minimal changes in
temperature during culture (away from 37 °C) for short
time periods can result in unrecoverable damage by
hurting the stability of the oocye/embryo spindle [35,
36]. The pH of medium also plays a crucial role in em-
bryo culture [34], while regulation of pH mostly relies
on the carbon dioxide (CO2) concentration.
The user manual of the EmbryoScope™, notes that
the instrument is equipped with unique temperature
controls, characterized by direct heat transfer to
individual media-filled wells. Temperature is alleged
to be virtually unchanged by opening the chamber
(<0.2 °C) when adding or removing embryos. Recov-
ery of CO2 concentrations is alleged to occur in less
than 5 min and of O2 in less than 15 min after clos-
ing of chamber. During this study, we. indeed, based
on the built-in monitoring software, did not note
temperature and/or CO2 concentration changes of
any significance.
It has been suggested that prolonged light exposure
required for time-lapse photography may negatively
affect embryos [14, 20, 37]. The EmbryoScopeTM,
however, uses long wave length light of lower inten-
sities (red light, 635 nm) than the light used in our
embryology laboratory during standard embryo assess-
ments under a microscope (15 % <550 nm). There
also are currently no experimental data in the litera-
ture to support any negative effects of greater light
exposure on embryos with use of the EmbryoScopeTM
[20, 26].
All of this leaves only one likely explanation for our
findings: The EmbryoScopeTM contains a microscope,
built into a compact incubator. During image capture,
the microscope is fixed, while the tray and culture
dish move slightly to focus each single well. Since in
our study, images were taken every 10 min, embryos
during three days of culture had to move at least 380
times. Though this embryo motion is very gentle and
mild, the impact of possible sheer stress cannot be
ruled out as a potential cause for observed declines
in embryo quality [34].
The effect may be statistically more apparent in
best prognosis patients because even a relative small
percentage loss in pregnancy in such a population
may be statistically more apparent. This also would
explain why the reported improvement in outcomes
in the Spanish study [27], which included only a little
less than half of best prognosis patients (ie, egg do-
nors) was only marginal. If our here laid out assump-
tions are correct, had the Spanish study included
even more oocyte donors (ie, good prognosis pa-
tients), it too, may no longer have demonstrated mar-
ginally better IVF cycle outcomes with the TLI system
or might even have drifted into the negative.
Mouse models that investigated the effects of mechan-
ical vibration induced shear stress on embryo develop-
ment, demonstrating decreased morula and blastocyst
formation [38], caused by phosphorylating mitogen-
activated protein kinase (MAPK) 8/9 [39]. Similar phos-
phorylation of MAPK 8/9 was never observed in control
embryo or in vivo cultured embryos.
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Conclusions
All of above noted considerations suggest that the most
likely explanation for the inferior performance of the
EmbryoScope™ in good prognosis donors is increased
exposure of embryos to shear stress. This is, however, as
of this point still a hypothesis, which requires experi-
mental confirmation. If confirmed, this negative finding
may not be applicable to other TLI systems with differ-
ent camera systems.
Because of its limited size, as already noted, here pre-
sented data have to be interpreted with caution. We also
have to acknowledge that we followed embryo outcomes
in this study only to cleavage-stage (day-3), while TLI
systems are primarily meant to be used to culture em-
bryos to blastocyst stage (days 5/6). Though unlikely, it
is possible that TLI systems affect prolonged embryo
culture more favorably. Since blastocyst stage culture
really only benefits good prognosis patients [31] this, at
best represents only a double-edged-sword since the op-
posite may actually also be true, and benefits of a TLI
system by day-3 may be overestimated.
This study, however, clearly demonstrates the need for
larger, well designed prospectively randomized studies
before TLI systems are placed into human embryology
laboratories for routine IVF care. It is also important to
point out that here reported study results cannot be gen-
eralized since they reflect the quality of our center’s
manual embryology. Outcome comparisons with manual
embryology may obviously differ at different embryology
laboratories.
If properly maintained, likely the quintessential advan-
tage of a TLI system is stability of its performance. Less
competent or less stable manual embryology may, there-
fore, indeed benefit from systems like the EmbryoScope™,
while superior manual embryology can, at least in good
prognosis patients, likely outperform TLI systems. A TLI
like the EmbryoScope™ may, thus, actually improve IVF
outcomes in programs with unstable embryology by sta-
bilizing performance; yet, in a program with excellent em-
bryology, effects may be the opposite.
In full disclosure, based on here reported study results,
our center for the time being is foregoing the purchase
of TLI systems.
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